Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study.

Low risk of mother-to-child transmission of human T lymphotropic virus type II in non-breast-fed infants. The NYC Perinatal HIV Transmission Collaborative Study.

Maternal antibodies to gp120 V3 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus.

Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission.

Persistently high perinatal transmission of HIV: assessment of risk factors.

Perinatal HIV-1 transmission: Fc gamma receptor variability associates with maternal infectiousness and infant susceptibility.

Prevention of Perinatal Hepatitis B Virus Transmission.

Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120.

Efficacy of WHO recommendation for continued breastfeeding and maternal cART for prevention of perinatal and postnatal HIV transmission in Zambia.

Evaluation of the natural perinatal transmission of bovine leukaemia virus.

HLA Class II Antigens and Their Interactive Effect on Perinatal Mother-To-Child HIV-1 Transmission.

Neonatal and perinatal infection: routes of transmission and prevention.

Hepatitis: Immunoregulation in pregnancy and perinatal transmission of HCV.

The role of the V3 loop of gp120 in HIV infection.

The Role of Maternal HIV Envelope-Specific Antibodies and Mother-to-Child Transmission Risk.

Prevention of perinatal transmission of hepatitis B virus carrier state.

V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity.

Characterization of a Large Panel of Rabbit Monoclonal Antibodies against HIV-1 gp120 and Isolation of Novel Neutralizing Antibodies against the V3 Loop.

Effect of lysine to arginine mutagenesis in the V3 loop of HIV-1 gp120 on viral entry efficiency and neutralization.

Analysis on the outcomes of hepatitis B virus perinatal vertical transmission: nested case-control study.

Mother-infant HIV transmission: do maternal HIV-specific antibodies protect the infant?

Molecular recognition of CCR5 by an HIV-1 gp120 V3 loop.

[Maternal and perinatal infections to Streptococcus agalactiae].

Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study.

Features of Maternal HIV-1 Associated with Lack of Vertical Transmission.

Suggest Documents

Low risk of mother-to-child transmission of human T lymphotropic virus type II in non-breast-fed infants. The NYC Perinatal HIV Transmission Collaborative Study.

Maternal antibodies to gp120 V3 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus.

Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission.

Persistently high perinatal transmission of HIV: assessment of risk factors.

Perinatal HIV-1 transmission: Fc gamma receptor variability associates with maternal infectiousness and infant susceptibility.

Prevention of Perinatal Hepatitis B Virus Transmission.

Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120.

Efficacy of WHO recommendation for continued breastfeeding and maternal cART for prevention of perinatal and postnatal HIV transmission in Zambia.

Evaluation of the natural perinatal transmission of bovine leukaemia virus.

HLA Class II Antigens and Their Interactive Effect on Perinatal Mother-To-Child HIV-1 Transmission.

Neonatal and perinatal infection: routes of transmission and prevention.

Hepatitis: Immunoregulation in pregnancy and perinatal transmission of HCV.

The role of the V3 loop of gp120 in HIV infection.

The Role of Maternal HIV Envelope-Specific Antibodies and Mother-to-Child Transmission Risk.

Prevention of perinatal transmission of hepatitis B virus carrier state.

V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity.

Characterization of a Large Panel of Rabbit Monoclonal Antibodies against HIV-1 gp120 and Isolation of Novel Neutralizing Antibodies against the V3 Loop.

Effect of lysine to arginine mutagenesis in the V3 loop of HIV-1 gp120 on viral entry efficiency and neutralization.

Analysis on the outcomes of hepatitis B virus perinatal vertical transmission: nested case-control study.

Mother-infant HIV transmission: do maternal HIV-specific antibodies protect the infant?

Molecular recognition of CCR5 by an HIV-1 gp120 V3 loop.

[Maternal and perinatal infections to Streptococcus agalactiae].

Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study.

Features of Maternal HIV-1 Associated with Lack of Vertical Transmission.

Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study.

Recommend Documents

Follow Us